Changes in motor and learning behaviors of rats prenatally exposed to WIN 55212-2, a cannabinoid receptor agonist

Physiology and Pharmacology

Volumn 13, Issue 2, 2009, Pages 120-129

  Shabani, Mohammad ^a,b   Haghani, Masoud ^a   Sheibani, Vahid ^b   Janahmadi, Mahyar ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cannabinoids; Maternal consumption; Memory; Motor performance

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ENDOCANNABINOID; POLYSORBATE 80;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; BODY WEIGHT; CONTROLLED STUDY; DRUG EXPOSURE; LATENT PERIOD; LEARNING; LITTER SIZE; MEMORY; MORTALITY; MOTOR COORDINATION; MOTOR PERFORMANCE; NONHUMAN; OUTCOME ASSESSMENT; PASSIVE AVOIDANCE; PREGNANCY; PREGNANT WOMAN; PRENATAL EXPOSURE; RAT; RIGHTING REFLEX; ROTAROD TEST; SHAM PROCEDURE;

EID: 77957873844     PISSN: 17350581     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Adams IB, Martin BR, Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (1996) 1585-1614.
2. Anja C, Eduard JH, Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev 30 (2006) 24-41.
3. Benagiano V, Lousso L, et al, Effect of prenatal exposure to CB-1 reseptor agonist WIN 55212-2 or CO on the GABAergic neuronal system or rat cerebellar cortex. Neurosci 149 (2007) 592-601.
4. Berrendero F, Garcia-Gil L, Hernandez ML, Romero J, Cebeira M, Miguel R, Ramos JA, Fernandez JJ, Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 125 (1998) 3179-3188.
5. Biegon A, Kerman IA, Autoradiographic study of preand postnatal distribution of cannabinoid receptors in human brain. Neuroimage 14 (2001) 1463-1468.
6. Block R, O'Leary D, Hichwa R, Augustinack J, Boles Ponto L, Ghoneim M, et al, Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav 72 (2002) 237-250.
7. Bortolato M, Frau R, Orrù M, Casti A, Nicola Aru G, Mauro F, Manunta M, Usai A, Mereu G, Luigi Gessa G, Prenatal exposure to a cannabinoid receptor agonist does not affect sensorimotor gating in rats. Eur J Pharmacol 531 (2006) 166-170.
8. Crawley JN. What's wrong with my mouse: behavioral phenotyping of transgenic and knockout mice. New York: Wiley-Liss, 2000.
9. Dursun I, Jakubowska-Doǧru E, Uzbay T, Effects of prenatal exposure to alcohol on activity, anxiety, motor coordination, and memory in young adult Wistar rats. Pharmacol Biochem Behav 85 (2006) 345-355. (Pubitemid 44881075)
10. Ebrahim SH, Gfroerer J, Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 101(2003) 374-379. (Pubitemid 36170140)
11. Fried PA, Watkinson B, Gray R, Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 25 (2003) 427-436. (Pubitemid 36700422)
12. Freund TF, Katona I, Piomelli D, Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83 (2003) 1017-1066. (Pubitemid 36828930)
13. Glass M, Dragunow M, Faull RL, Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neurosci 77 (1997) 299-318. (Pubitemid 27079604)
14. Herkenham M, Lynn AB, Little DM, Johnson MR, Melvin LS, De Costa BR, Rice KC, Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87 (1990) 1932-1936.
15. Hutchings DE, Martin BR, Gamagaris Z, Miller N, Fico T, Plasma concentration of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci 44 (1989) 697-701. (Pubitemid 19065969)
16. Jager G, Van Hell HH, De Win MM, Kahn RS, Van Den Brink B, et al, Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol 17 (2007) 289-297. (Pubitemid 46156994)
17. Jing L, Jiang-Hua Y, He-Zhen WU, Qun W, Extract from Fructus cannabis activating calcineurin improved learning and memory in mice with chemical drug-induced dysmnesia. Acta Pharmacol Sin 24 (2003) 1137-1142.
18. Joy JE, Watson S J, Benson JA, Marijuana and Medicine Assessing the Science Base. Washington, DC, National Academy (1999).
19. Liang Y, Huang C, Hsu K, The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain. Neuropharmacology 53 (2007) 169-177. (Pubitemid 47125956)
20. Masur J, Martz RM, Carlini EA, Effects of acute and chronic administration of cannabis sativa and (-) h9- transtetrahydrocannabinol on the behavior of rats in an open field. Psychopharmacologia 19 (1971) 388.
21. Matochik JA, Eldreth DA, Cadet JL, Bolla KI, Altered brain tissue composition in heavy marijuana users.Drug Alcohol Depend 77 (2005) 23-30.
22. Mereu G, Fa M, Ferraro L, Cagiano R, Antonelli T, Tattoli M, Ghiglieri V, Tanganelli S, Gessa GL, Cuomo V, Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A 100 (2003) 4915-4920.
23. Miller L, Wikler G, Drew P, A9-THC: Effect on acquisition and retention of a one-trial passive avoidance response. Behav Biol 8(1973) 421.
24. Navarro M, Rubio P, de Fonseca FR, Behavioral consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology 122 (1995) 1-14.
25. Nestor L, Roberts G, Garavan H. and Robert H. Deficits in learning and memory: Parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. NeuroImage 40 (2008) 1328-1339.
26. Paola Castelli M, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Luigi Gessa G, Maccarrone M, Pistis M, Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 . Eur J Pharmacol 573 (2007) 11-19. (Pubitemid 47464211)
27. Richard M. Vardaris and Donald J, Chronic Administration of Delta-9-tetrahydrocannabinol to Pregnant Rats: Studies of Pup Behavior and Placental Transfer. Pharmacol Biochem Behav 4 (1976) 249-254.
28. Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L, Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol 24 (2002) 309-320. (Pubitemid 34493899)
29. Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, Sim-Selley LJ, Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. J Neurochem 77 (2001) 1048-1057. (Pubitemid 32467059)
30. van der Stelt M, Mazzola C, Esposito G, Matias I, Petrosino S, De Filippis D, Micale V, Steardo L, Drago F, Iuvone T, Di Marzo V, Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci. 63(2006) 1410-1424.
31. Viveros MP, Llorente R, Moreno E, Marco EM, Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol 16 (2005) 353-362. (Pubitemid 41404806)